Invesaro

Stocks Health care PMI

NYSE · Health care

Picard Medical, Inc. (PMI)

Picard Medical, Inc. brought in $6.3M of revenue over the twelve months to June 30, 2026. It posted a net loss of $28M. At June 30, 2026 it held $38K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Watch PMI in 60 seconds
Revenue (last 12 months)
$6.3M
Net margin
-444.8%

What Picard Medical, Inc. does

Picard Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker PMI.

Revenue and profit by year

Revenue
FY25: $4.4M $4.4M FY25FY25: $4.9M $4.9M FY25
Net income
FY25: -$21.1M -$21.1M FY25FY25: -$27M -$27M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$4.9M-$13.3M-$27M-$0.75n/a
2025$4.4M-$13.7M-$21.1M-$2.99n/a

Full financial statements: income, balance sheet and cash flow

Where PMI ranks in Health care

Revenue$4.9M
#508 of 646 in Health care · Bottom 21%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Picard Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 20, 2026
  2. August 19, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 39% to $3M versus the same quarter last year; diluted EPS -$3.05 versus -$42.39.
  3. August 17, 2026
  4. August 7, 2026
  5. July 27, 2026
  6. July 22, 2026
  7. July 21, 2026
  8. July 16, 2026
  9. July 13, 2026
  10. July 8, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 3, 2026. Insider transactions on SEC

Who owns PMI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Hudson Bay Capital Management LP13G, passive with 1 related filers 9.99% 11,390,442 August 7, 2026

Latest filings below 5%: Sindex SSI Lending, LLC 0% (June 5, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PMI

What does Picard Medical, Inc. do?

Picard Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker PMI.

Is Picard Medical, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $28M on revenue of $6.3M.

How much revenue does Picard Medical, Inc. make?

Over the twelve months to June 30, 2026 Picard Medical, Inc. reported revenue of $6.3M.

When did Picard Medical, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from August 20, 2026.

Similar companies

Compare PMI with

Compare PMI with any company

Follow PMI

Get an email when Picard Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PMI: get an email when it files

Where the numbers come from

Financial figures are the values Picard Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.